US Stock MarketDetailed Quotes
XBIT XBiotech
- 6.685
- +0.375+5.94%
Trading Jul 25 12:59 ET
203.61MMarket Cap-6618P/E (TTM)
6.700High6.290Low17.82KVolume6.300Open6.310Pre Close115.62KTurnover0.09%Turnover RatioLossP/E (Static)30.46MShares9.96052wk High0.97P/B132.51MFloat Cap3.51052wk Low--Dividend TTM19.82MShs Float28.003Historical High--Div YieldTTM6.50%Amplitude1.835Historical Low6.489Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
XBiotech Stock Forum
XBiotech (NASDAQ: XBIT) recently announced promising data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Named 1-BETTER, this study focused on evaluating Natrunix, an anti-interleukin-1alpha antibody, in combination with a well-established chemotherapy regimen comp...
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
XBiotech (NASDAQ: XBIT) announced promising results from its Phase 1/2 trial for advanced pancreatic cancer treatment using Natrunix in combination with a standard chemotherapy regimen. The study, titled 1-BETTER, enrolled 65 subjects who received either the Natrunix combination or a placebo. Key findings include a 28% reduction in signif...
Where can check this information?
If I have 10 share....
Where is the money? 🧐
No comment yet